CC(=O)O[C@H]1CC[C@@]2(C)C(=C/C(=N\[N+](=O)[O-])[C@@H]3C2CC[C@@]2(C)C3CCC2[C@H](C)CCCC(C)C)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?